BISU News Bio-Solutions Corp. Shareholder Updat

SAN ANTONIO, Aug. 10, 2012 /PRNewswire/ -- Bio-Solutions Corp, (OTCQB: BISU) (PINKSHEETS: BISU)is pleased to provide a shareholder update on recent news, events and the state of the company as a whole.

Since the acquisition Type2 Defense™ , (T2), in Sept of 2011, the company has engaged in running a test trail in an American suburban community, (composed of 1500 individuals), of the T2 product. The purpose of this test trail is to gauge the response and feedback from a segment of the population, towards the Type2 Defense™ product.

Type2 Defense™ (the "Product" or the "Supplement") is a glucose control dietary supplement powder formulated to help support healthy glucose levels, in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for Type II Diabetics and Pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

Type II Diabetes and Pre-diabetics, account for over 90% of all diabetic cases. The product is delivered in 10 gram plastic packets (i.e. Emergent- C). The targeted market is health conscious individuals that have been diagnosed as Type II Diabetics or individuals who are concerned with Pre-diabetic symptoms.

According the Nation Diabetes Foundation: Type II Diabetes is the most common form of diabetes. Over 133 Million Americans have been diagnosed with Type II Diabetes, and many more are unaware they are at high risk. Some groups have a higher risk for developing Type II Diabetes than others. Increasing at about Two Million new American patients per year.